NL8301913A - Middel voor het versterken van de antitumor activiteit van een middel tegen tumoren. - Google Patents

Middel voor het versterken van de antitumor activiteit van een middel tegen tumoren. Download PDF

Info

Publication number
NL8301913A
NL8301913A NL8301913A NL8301913A NL8301913A NL 8301913 A NL8301913 A NL 8301913A NL 8301913 A NL8301913 A NL 8301913A NL 8301913 A NL8301913 A NL 8301913A NL 8301913 A NL8301913 A NL 8301913A
Authority
NL
Netherlands
Prior art keywords
tumor
agent
diltiazem
acid addition
addition salt
Prior art date
Application number
NL8301913A
Other languages
English (en)
Dutch (nl)
Original Assignee
Japan Found Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Found Cancer filed Critical Japan Found Cancer
Publication of NL8301913A publication Critical patent/NL8301913A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NL8301913A 1982-05-28 1983-05-30 Middel voor het versterken van de antitumor activiteit van een middel tegen tumoren. NL8301913A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP57091850A JPS58208222A (ja) 1982-05-28 1982-05-28 抗腫瘍剤効果増強剤
JP9185082 1982-05-28

Publications (1)

Publication Number Publication Date
NL8301913A true NL8301913A (nl) 1983-12-16

Family

ID=14038043

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8301913A NL8301913A (nl) 1982-05-28 1983-05-30 Middel voor het versterken van de antitumor activiteit van een middel tegen tumoren.

Country Status (11)

Country Link
US (1) US4628047A (it)
JP (1) JPS58208222A (it)
BE (1) BE896872A (it)
CH (1) CH654212A5 (it)
DE (1) DE3319347A1 (it)
DK (1) DK239883A (it)
FR (1) FR2527441B1 (it)
GB (1) GB2120941B (it)
IT (1) IT1208480B (it)
NL (1) NL8301913A (it)
SE (1) SE462076B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59231018A (ja) * 1983-06-10 1984-12-25 Tanabe Seiyaku Co Ltd 抗脂血剤
FR2593395A1 (fr) * 1986-01-28 1987-07-31 Corbiere Jerome Nouvelles compositions pharmaceutiques antiglaucomateuses a base de 3-acetoxy-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepine-4-one ou d'un de ses sels et leur procede d'obtention
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
DE3705117A1 (de) * 1987-02-18 1988-09-01 Goedecke Ag Verwendung von benzothiazepin-derivaten, insbesondere diltiazem bei der protektion von lymphozyten
US5112954A (en) * 1988-02-26 1992-05-12 Neorx Corporation Method of enhancing the effect of cytotoxic agents
US5114951A (en) * 1989-04-11 1992-05-19 Burroughs Wellcome Company Agents for combating multiple drug resistance
US5208238A (en) * 1989-06-19 1993-05-04 Burroughs Wellcome Company Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
GB8914060D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914040D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914061D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
JPH04506072A (ja) * 1989-06-19 1992-10-22 ザ・ウエルカム・ファウンデーション・リミテッド 癌治療に有用であり、かつ抗ヒスタミン特性を有する医薬
GB8914062D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
CA2030159A1 (en) * 1989-11-22 1991-05-23 Nahed K. Ahmed Anti-cancer drug potentiators
CA2030160A1 (en) * 1989-11-22 1991-05-23 Nahed K. Ahmed Benzothiazepine metastasis treatment
JPH0497451U (it) * 1991-01-16 1992-08-24
GB2291279B (en) * 1994-06-24 1998-07-15 Thomas & Betts Corp Improvements in or relating to electrical connection apparatus
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof

Also Published As

Publication number Publication date
SE8303003D0 (sv) 1983-05-27
GB8314588D0 (en) 1983-06-29
SE462076B (sv) 1990-05-07
FR2527441B1 (fr) 1986-05-09
CH654212A5 (de) 1986-02-14
GB2120941A (en) 1983-12-14
IT1208480B (it) 1989-07-10
GB2120941B (en) 1986-09-10
IT8321348A0 (it) 1983-05-27
US4628047A (en) 1986-12-09
DE3319347A1 (de) 1983-12-01
JPS58208222A (ja) 1983-12-03
DE3319347C2 (it) 1992-03-19
JPS6343366B2 (it) 1988-08-30
FR2527441A1 (fr) 1983-12-02
DK239883D0 (da) 1983-05-27
SE8303003L (sv) 1983-11-29
DK239883A (da) 1983-11-29
BE896872A (fr) 1983-09-16

Similar Documents

Publication Publication Date Title
JP7523351B2 (ja) 肥満細胞症の治療のための併用療法
NL8301913A (nl) Middel voor het versterken van de antitumor activiteit van een middel tegen tumoren.
Wittes et al. Combination chemotherapy with cis-diamminedichloroplatinum (II) and bleomycin in tumors of the head and neck
Hellmann et al. Preliminary clinical assessment of ICRF 159 in acute leukaemia and lymphosarcoma
US20020198160A1 (en) Compositions and methods for enhancing the bioavailability of pharmaceutical agents
EP0344880B1 (en) Pharmaceutical compositions with anti-cancer activity
WO2019217164A1 (en) Compositions and methods for treating cancer and other diseases
Olweny et al. Treatment of Burkitt's lymphoma: randomized clinical trial of single‐agent versus combination chemotherapy
EP1757283B1 (en) Antitumor effect fortifier, antitumor agent and method of therapy for cancer
RU2519199C2 (ru) Противоопухолевый агент, набор и способ лечения рака
KR100844477B1 (ko) 항종양 효과 증강제, 항종양제 및 암 치료 방법
EP2384752A1 (de) Kombinationspräparat umfassend einen Phosphodiesterasehemmer und einen COX-Inhibitor zur Behandlung von Krebs
RU2471486C2 (ru) Противоопухолевое средство для непрерывного внутривенного введения, содержащее цитидиновое производное
JP2767176B2 (ja) 抗癌剤
WO2022169690A1 (en) Composition and methods for treating cancer
Lippens Methotrexate in the central nervous system prophylaxis of children with acute lymphoblastic leukemia
JP2836797B2 (ja) 血小板減少症およびまたは白血球減少症治療剤
Forastiere et al. Bisantrene (NSC 337766)(CL 216,942) in advanced breast cancer: A cancer and leukemia group B study
JP5581200B2 (ja) シチジン誘導体及びカルボプラチンを含有する抗腫瘍剤
JPS6337767B2 (it)
CA2189097A1 (en) Composition and method of treating retroviral infection
JPS5925325A (ja) 癌治療剤
JPS6231689B2 (it)
JPH06107548A (ja) 癌の肝転移抑制剤及び肝癌の治療剤

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed